U-BIOPRED (Unbiased BIOmarkers in PREDiction of respiratory disease outcomes) is a research project to understand more about severe asthma that involves scientists from universities, research institutes, the pharmaceutical industry and small companies.
The IMI aims to bring together industrial partners and university researchers, in an attempt to reduce barriers or bottlenecks that slow down the development of new medicines. It is also one of the first occasions that so many pharmaceutical companies are working together on the same project as partners and not as competitors.
Aim of the project
The overall aim of U-BIOPRED is to better understand the different types of severe asthma with the hope that this understanding will consider individual characteristics and make it easier to develop new medicines.